Full Text View
Tabular View
No Study Results Posted
Related Studies
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
This study has been terminated.
( DSMB stopped the study based on conclusion of likely futility of treatment on the primary outcome. )
Study NCT00123539   Information provided by National Heart, Lung, and Blood Institute (NHLBI)

First Received on July 21, 2005.   Last Updated on December 17, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Disease
Cardiovascular Diseases
Heart Diseases
Neurologic Manifestations
Additional conditions recognized in this trial
Coronary Artery Disease
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Myocardial Ischemia
Nervous System Diseases
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
Estrogen Replacement Therapy
Surgery
Additional drug interventions recognized in this trial
Estrogens
More general drug interventions related to this trial
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services